The Ezetimibe Market is witnessing significant expansion globally, fueled by an increasing prevalence of cardiovascular diseases (CVDs) and a rising focus on cholesterol management. As one of the leading lipid-lowering agents, ezetimibe is widely prescribed to patients struggling with high cholesterol, particularly those unresponsive to statins alone.
With escalating public health campaigns...